144 related articles for article (PubMed ID: 12041852)
1. Monoclonal gammopathy of undetermined significance: new insights.
Chen BH
CMAJ; 2002 May; 166(10):1309. PubMed ID: 12041852
[No Abstract] [Full Text] [Related]
2. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Rajkumar SV; Lacy MQ; Kyle RA
Blood Rev; 2007 Sep; 21(5):255-65. PubMed ID: 17367905
[TBL] [Abstract][Full Text] [Related]
3. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].
Uchida M; Taida N; Kanao M; Kagamihara H; Kuwajima M
Rinsho Byori; 2004 Jul; 52(7):574-9. PubMed ID: 15344556
[TBL] [Abstract][Full Text] [Related]
4. Neuromuscular disorders associated with paraproteinemia.
Hoffman-Snyder C; Smith BE
Phys Med Rehabil Clin N Am; 2008 Feb; 19(1):61-79, vi. PubMed ID: 18194750
[TBL] [Abstract][Full Text] [Related]
5. Lack of serologic association of human herpesvirus-8 (KSHV) in patients with monoclonal gammopathy of undetermined significance with and without progression to multiple myeloma.
Ablashi DV; Chatlynne L; Thomas D; Bourboulia D; Rettig MB; Vescio RA; Viza D; Gill P; Kyle RA; Berenson JR; Whitman JE
Blood; 2000 Sep; 96(6):2304-6. PubMed ID: 10979981
[TBL] [Abstract][Full Text] [Related]
6. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance.
Leleu X; Le Friec G; Facon T; Amiot L; Fauchet R; Hennache B; Coiteux V; Yakoub-Agha I; Dubucquoi S; Avet-Loiseau H; Mathiot C; Bataille R; Mary JY;
Clin Cancer Res; 2005 Oct; 11(20):7297-303. PubMed ID: 16243800
[TBL] [Abstract][Full Text] [Related]
7. [Multiple myeloma with Sweet disease developing from monoclonal gammopathy of undetermined significance and Sjögren syndrome].
Harada Y; Egi Y; Honda Y; Shirota T; Hayashi T
Rinsho Ketsueki; 2001 Dec; 42(12):1176-80. PubMed ID: 11828720
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; Rajkumar SV
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1093-113, ix. PubMed ID: 17996590
[TBL] [Abstract][Full Text] [Related]
9. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
[TBL] [Abstract][Full Text] [Related]
10. Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy.
Morra E; Cesana C; Klersy C; Varettoni M; Cavanna L; Canesi B; Tresoldi E; Barbarano L; Lazzarino M;
Semin Oncol; 2003 Apr; 30(2):172-7. PubMed ID: 12720131
[TBL] [Abstract][Full Text] [Related]
11. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance.
Rajkumar SV; Kyle RA; Therneau TM; Clark RJ; Bradwell AR; Melton LJ; Larson DR; Plevak MF; Katzmann JA
Br J Haematol; 2004 Nov; 127(3):308-10. PubMed ID: 15491291
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
Kyle RA; Rajkumar SV
Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
[TBL] [Abstract][Full Text] [Related]
13. Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance.
Rossi F; Petrucci MT; Guffanti A; Marcheselli L; Rossi D; Callea V; Vincenzo F; De Muro M; Baraldi A; Villani O; Musto P; Bacigalupo A; Gaidano G; Avvisati G; Goldaniga M; Depaoli L; Baldini L
Clin Cancer Res; 2009 Jul; 15(13):4439-45. PubMed ID: 19509142
[TBL] [Abstract][Full Text] [Related]
14. [The pathology of smoldering multiple myeloma].
Shibayama H
Nihon Rinsho; 2015 Jan; 73(1):33-7. PubMed ID: 25626300
[TBL] [Abstract][Full Text] [Related]
15. [Monoclonal gammopathy of undetermined significance].
Chaïbi P; Merlin L; Thomas C; Piette F
Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of a population based cohort with monoclonal proteinaemia.
Schaar CG; le Cessie S; Snijder S; Franck PF; Wijermans PW; Ong C; Kluin-Nelemans H
Br J Haematol; 2009 Jan; 144(2):176-84. PubMed ID: 19036113
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR
Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance.
Kumar S; Rajkumar SV; Kyle RA; Lacy MQ; Dispenzieri A; Fonseca R; Lust JA; Gertz MA; Greipp PR; Witzig TE
J Clin Oncol; 2005 Aug; 23(24):5668-74. PubMed ID: 16110026
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal gammopathy in search of clinical significance: 57 years later.
Go RS; Doyle LM
Blood; 2009 Sep; 114(11):2355-6; author reply 2356-7. PubMed ID: 19745077
[No Abstract] [Full Text] [Related]
20. The significance of soluble CD138 in diagnosis of monoclonal gammopathies.
Maisnar V; Tousková M; Tichý M; Krejsek J; Chrobák L; Voglová J; Malý J
Neoplasma; 2006; 53(1):26-9. PubMed ID: 16416009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]